2-200412340-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001100423.2(SPATS2L):c.69C>A(p.Asn23Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000106 in 1,598,278 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001100423.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPATS2L | NM_001100423.2 | c.69C>A | p.Asn23Lys | missense_variant | 4/13 | ENST00000409140.8 | NP_001093893.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPATS2L | ENST00000409140.8 | c.69C>A | p.Asn23Lys | missense_variant | 4/13 | 2 | NM_001100423.2 | ENSP00000386730.3 |
Frequencies
GnomAD3 genomes AF: 0.00000671 AC: 1AN: 148994Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000126 AC: 3AN: 237976Hom.: 0 AF XY: 0.0000155 AC XY: 2AN XY: 128822
GnomAD4 exome AF: 0.0000110 AC: 16AN: 1449284Hom.: 0 Cov.: 30 AF XY: 0.00000833 AC XY: 6AN XY: 720330
GnomAD4 genome AF: 0.00000671 AC: 1AN: 148994Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 1AN XY: 72440
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 25, 2024 | The c.69C>A (p.N23K) alteration is located in exon 4 (coding exon 2) of the SPATS2L gene. This alteration results from a C to A substitution at nucleotide position 69, causing the asparagine (N) at amino acid position 23 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at